PLYGF (PolyPeptide Group AG) Short-Term Debt: $0.6 Mil (As of Dec. 2025)


PLYGF PolyPeptide Group AG PLYGF
61 GF Score
Price $43.00
GF Value $40.58
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PolyPeptide Group AG Short-Term Debt?

PolyPeptide Group AG PLYGF 61 Short-Term Debt is $0.6 Mil as of Dec. 2025. GuruFocus rates PLYGF with a GF Score™ of 61/100 and a GF Value™ of $40.58 (Fairly Valued). The stock has 8 warning signs investors should review.

PolyPeptide Group AG's Short-Term Debt for the quarter that ended in Dec. 2025 was $0.6 Mil.

PolyPeptide Group AG's quarterly Short-Term Debt declined from Dec. 2024 ($32.1 Mil) to Jun. 2025 ($0.7 Mil) and declined from Jun. 2025 ($0.7 Mil) to Dec. 2025 ($0.6 Mil).

PolyPeptide Group AG's annual Short-Term Debt declined from Dec. 2023 ($45.0 Mil) to Dec. 2024 ($32.1 Mil) and declined from Dec. 2024 ($32.1 Mil) to Dec. 2025 ($0.6 Mil).

PolyPeptide Group AG Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PolyPeptide Group AG Short-Term Debt Related Terms

PolyPeptide Group AG Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG Short-Term Debt Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 0.00 0.00 44.99 32.09 0.64

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.99 44.37 32.09 0.70 0.64
PLYGF
61GF Score
PolyPeptide Group AG PLYGF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.6 Mil mean?
PolyPeptide Group AG (PLYGF) has a Short-Term Debt of $0.6 Mil as of Dec. 2025.
Is PolyPeptide Group AG's Short-Term Debt too high?
PolyPeptide Group AG's current Short-Term Debt is $0.6 Mil. Overall, PolyPeptide Group AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's Short-Term Debt compare to ZTS and UTHR?
PolyPeptide Group AG's Short-Term Debt of $0.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PolyPeptide Group AG's current Short-Term Debt is $0.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (PLYGF) is currently considered Fairly Valued. The stock's GF Value™ is $40.58, compared to a current price of $43.00 — trading 6% above its estimated fair value. The current Short-Term Debt is $0.6 Mil. PolyPeptide Group AG's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PolyPeptide Group AG (PLYGF), the current Short-Term Debt is $0.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (PLYGF) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of $43.00 is trading 6% above its estimated GF Value™ of $40.58. GuruFocus considers PolyPeptide Group AG to be Fairly Valued.

Key valuation signals for PLYGF:

  • Short-Term Debt: $0.6 Mil
  • GF Value™: $40.58 vs. price of $43.00 (6% above fair value)
  • GF Score™: 61/100 with 8 warning signs

No single metric tells the full story. See the PLYGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
61GF Score

Get the complete analysis for PLYGF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.00
Price
$40.58
GF Value